M. Goudier

Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group.

J. Bonneterre, A. Monnier, I. van Praagh, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial.

T. Delozier, J. Bonneterre, B. Asselain, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagus.

B. Dubray, J. Douillard, P. Martin, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial.

S. Schraub, M. Namer, J. Bonneterre, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.

S. Schraub, M. Namer, J. Bonneterre, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationship between 5‐fluorouracil (5‐FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5‐FU

E. Gamelin, P. Gesta, A. Lortholary, 1996, Cancer.

Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node‐positive, early‐stage, invasive breast carcinoma undergoing breast‐conserving surgery

A. Courdi, A. Monnier, D. Berton‐Rigaud, 2005, Cancer.

Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study

E. Blot, P. Ingrand, J. Douillard, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.